Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Vivalyx GmbH

Clinicaltrial registered6 Nov 2026

Vivalyx GmbH

6 Nov 2026: Trial registered · Hypothermic Kidney Machine Perfusion With Omnisol. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
6 Nov 2026
Title
Hypothermic Kidney Machine Perfusion With Omnisol
Conditions
End Stage Renal Disease (ESRD), Kidney Transplant, Kidney Failure, Renal and Urinary Tract Therapeutic Procedures
Phase
Not applicable
Study Type
Interventional
Status
Not Yet Recruiting
Reference
NCT07920926
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Vivalyx GmbH

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.